Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

AiChemist Explainable AI for Molecules - AiChemist

Coordinator
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH, Germany
Runs
1 September 2023 to 31 August 2027
Status
Running
EU funding
€3.0m
Total cost
—
Partners
29 organisations in 11 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101120466

What the project is doing

In the project's own words, from its summary on CORDIS.

Optimising biological activity and physico-chemical properties, while minimising their toxicity, are objectives when developing new compounds in chemical industries. Advanced machine learning (AI) methods are indispensable to this process. They are also increasingly used in environmental chemistry to identify compounds damaging to the environment and humans. Traditional machine learning (ML) methods provide reliable predictions though only for compounds similar to the training set, thus defining their applicability domain (AD).

Emerging representation learning approaches can efficiently approximate the physical interactions of molecules with an accuracy comparable to physics-based methods in only fractions of time. Models based on these representations should have much larger AD due to pre-training on large chemical sets of theoretical values. Here we will develop and benchmark representation learning approaches, addressing their accuracy and ADs, using public and in-house data for endpoints ranging from chemical reactions to toxicity.

While explainable AI (XAI) methods are actively developing in the ML community, there is a gap with their use in chemistry, i.e. there is a need to translate their results to the end users, chemists and regulatory bodies. Since the research program is tightly coupled with the target users - large companies, regulatory agencies and SMEs - it provides a clear path for technology transfer from academia to industry. AiChemist will provide structured training to its fellows through a combination of online courses and schools, strengthening European innovation capacity in the education of specialists in AI methods.

The fellows will receive comprehensive training in transferable skills. The complementary expertise and strong commitment of the partners make this ambitious innovative research program realistic via the proper allocation of individual tasks and resources, as described below.

Who is involved

OrganisationCityCountryRole
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbHNeuherbergGermanyCoordinator
Chelonia SALuganoSwitzerlandAssociatedpartner
Ecole Polytechnique Federale De LausanneLausanneSwitzerlandAssociatedpartner
Syngenta Crop Protection AGBaselSwitzerlandAssociatedpartner
Universita Della Svizzera ItalianaLuganoSwitzerlandAssociatedpartner
Ascenion GmbHMunichGermanyAssociatedpartner
Bayer AktiengesellschaftLeverkusenGermanyParticipant
Bigchem GmbHUnterschleiheimGermanyAssociatedpartner
Molecular Networks GmbH ComputerchemieNurnbergGermanyParticipant
Pfizer Pharma GmbHBerlinGermanyParticipant
Technische Universitaet MuenchenMuenchenGermanyParticipant
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Universitat De BarcelonaBarcelonaSpainAssociatedpartner
European Chemicals AgencyHelsinkiFinlandAssociatedpartner
CehtraCenonFranceAssociatedpartner
Ecole Normale SuperieureParisFranceParticipant
Sanofi-Aventis Recherche & DeveloppementGentillyFranceParticipant
Sorbonne UniversiteParisFranceAssociatedpartner
Universite De StrasbourgStrasbourgFranceParticipant
Istituto Di Ricerche Farmacologiche Mario NegriMilanoItalyParticipant
Korea Research Institute of Chemical TechnologyDaejeonSouth KoreaAssociatedpartner
Technische Universiteit EindhovenEindhovenNetherlandsParticipant
Universiteit LeidenLeidenNetherlandsParticipant
Astrazeneca ABSodertaeljeSwedenParticipant
Altamira LlcColumbus OhUnited StatesAssociatedpartner
National Institutes of HealthBethesdaUnited StatesAssociatedpartner
U.S. Food & Drug AdministrationSilver SpringUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI